We are pleased to announce that we have completed a 100% exit from ASX listed Integral Diagnostics through the sale of our remaining shares which were released from escrow in August 2016.
Integral Diagnostics was successfully listed on the ASX in October 2015. The IPO saw us reduce our shareholding by 50% and returning more than the original invested capital to investors after 14 months. Total proceeds for the Fund and co-investors, post our final exit, represent a 63% IRR (2.0x money multiple) on a 2 year investment hold.
Download our latest newsletter: